Question 1

What is Ipilimumab?

Accepted Answer

Ipilimumab is a type of medication known as a monoclonal antibody. It works as an immunotherapy by helping the body's own immune system recognize and destroy cancer cells.

By targeting specific proteins that act as brakes on the immune system, this medication allows immune cells to become more active in fighting the disease. This approach is designed to slow or stop the growth of certain types of tumors.

Question 2

What is Ipilimumab used for?

Accepted Answer

Ipilimumab is used to treat the following conditions:

Melanoma

Renal cell carcinoma

Colorectal cancer

Others

Question 3

How does Ipilimumab work?

Accepted Answer

Mechanism of Action

Ipilimumab belongs to a class of drugs known as monoclonal antibodies. It is specifically designed to act as an immune checkpoint inhibitor. This means it targets certain proteins in the body that control the immune system's response.

Targeting CTLA-4

The immune system uses checkpoints to prevent it from attacking healthy cells. One of these checkpoints is a protein called CTLA-4, which is found on the surface of T-cells (a type of white blood cell). CTLA-4 acts like a brake, slowing down or stopping the immune response to prevent it from becoming overactive.

How It Fights Cancer

Ipilimumab works by binding to the CTLA-4 protein. By doing this, it blocks the brake signal, which allows the T-cells to remain active and multiply. This enhanced immune response helps the body's own defense system to:

Recognize cancer cells as a threat.

Attack and destroy tumor cells throughout the body.

Potentially slow or stop the growth of the cancer.

Because this medication stimulates the immune system generally, it may also cause the immune system to attack healthy tissues and organs in some cases.

Question 4

What are the brand names for Ipilimumab?

Accepted Answer

Ipilimumab is sold under the brand name Yervoy .

Question 5

What are the active ingredients in Ipilimumab?

Accepted Answer

The active ingredient in Ipilimumab is ipilimumab .

Question 6

What are the side effects of Ipilimumab?

Accepted Answer

Common side effects of Ipilimumab may include:

diarrhea

fatigue

rash

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Ipilimumab?

Accepted Answer

Ipilimumab belongs to the CTLA-4 immune checkpoint inhibitor drug class.

Question 8

What is the dosage of Ipilimumab and how do I take it?

Accepted Answer

Administration

Ipilimumab is given as an injection into a vein (intravenous infusion) by a doctor or nurse in a hospital or clinic. The infusion process typically takes between 30 and 90 minutes to complete, depending on the specific treatment plan.

Treatment Schedule

This medication is usually administered once every few weeks. It may be used alone or in combination with other immunotherapy medications. Your healthcare provider will determine the appropriate schedule and the total number of doses based on the condition being treated and how your body responds to the therapy.

Missed Doses

Because ipilimumab is administered by a healthcare professional, it is important to keep all scheduled appointments. If you miss an appointment for an infusion, contact your doctor or the medical facility as soon as possible to reschedule your treatment.

Question 9

Is Ipilimumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Ipilimumab can cause harm to an unborn baby. Healthcare providers typically advise against using this medication during pregnancy unless the potential benefit justifies the potential risk to the fetus. If you are pregnant or planning to become pregnant, discuss the risks and benefits with your doctor.

Contraception

Females who are able to become pregnant should use effective birth control during treatment with ipilimumab. This contraception should be continued for at least 3 months after the final dose to prevent pregnancy.

Breastfeeding

It is currently unknown whether ipilimumab passes into human breast milk. Due to the risk of serious side effects in a nursing child, it is generally recommended that individuals do not breastfeed during treatment and for at least 3 months after the last dose. Consult with a healthcare professional to discuss the best way to feed your baby during this time.

Question 10

What forms and strengths does Ipilimumab come in?

Accepted Answer

Available Forms

Ipilimumab is available as a solution for injection. It is administered as an intravenous (IV) infusion, meaning the medication is delivered directly into a vein over a specific period of time.

This medication is typically provided in single-dose vials. Because it must be administered by a healthcare professional in a medical facility, it is not available for self-administration or in oral forms such as tablets or capsules.

Question 11

What is the FDA approval status of Ipilimumab?

Accepted Answer

FDA Approval and Indications

Ipilimumab was first approved by the U.S. Food and Drug Administration (FDA) in 2011. It is currently approved for the treatment of several types of cancer, often when the disease is advanced, has spread to other parts of the body, or cannot be removed by surgery. Approved uses include:

Melanoma: Used alone or with other medications for advanced melanoma or as a follow-up treatment after surgery to prevent recurrence.

Renal Cell Carcinoma: Used in combination with nivolumab for certain patients with advanced kidney cancer.

Colorectal Cancer: Approved for use with nivolumab in patients with specific genetic markers (MSI-H or dMMR) whose cancer has progressed after chemotherapy.

Hepatocellular Carcinoma: Used with nivolumab for patients with liver cancer who have previously been treated with sorafenib.

Lung Cancer and Mesothelioma: Approved for specific types of non-small cell lung cancer and malignant pleural mesothelioma, typically in combination with other immunotherapies or chemotherapy.

Boxed Warning

The FDA has issued a boxed warning for ipilimumab because it can cause the body's immune system to attack healthy organs and tissues. These immune-mediated adverse reactions can be severe or fatal. They most commonly affect the:

Intestines (colitis)

Liver (hepatitis)

Skin (dermatitis)

Nerves (neuropathy)

Endocrine glands (hormone-producing glands)

Healthcare providers monitor patients closely for these reactions during and after treatment. If severe symptoms occur, treatment may need to be paused or permanently discontinued, and corticosteroid medications may be required to manage the inflammation.

Question 12

What should I know about Ipilimumab and cost?

Accepted Answer

Factors Influencing Cost

Ipilimumab is a specialized biologic therapy administered as an intravenous infusion. Several factors determine the total cost of treatment:

Dosage: The amount of medication needed is often calculated based on the patient's body weight.

Treatment Regimen: Costs may increase when ipilimumab is used in combination with other immunotherapy drugs.

Administration Fees: Because it must be given in a clinical setting by healthcare professionals, patients may incur additional charges for the facility and professional services.

Insurance and Financial Assistance

Most insurance providers, including Medicare, cover ipilimumab for approved uses, but patients often require prior authorization from their insurance company before starting treatment. Out-of-pocket expenses like deductibles and coinsurance can still be substantial.

Financial assistance programs or copay cards may be available through the drug manufacturer or non-profit organizations to help eligible patients manage the cost of the medication.

Ipilimumab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?